+467.0%
MRNA vs CAVA
-14.0%
+481.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CAVA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +3.5% | +1.9% | +4.1% |
| 7D | -1.1% | -8.0% | +6.9% | +1.9% |
| 30D | +126.1% | -19.6% | +145.7% | +145.0% |
| 3M | +190.0% | -36.7% | +226.7% | +222.5% |
| 6M | +157.2% | -30.6% | +187.8% | +182.3% |
| YTD | +388.2% | -4.8% | +393.0% | +416.8% |
| 1Y | +467.0% | -13.1% | +480.2% | +468.4% |
| All | +467.0% | -14.0% | +481.1% | +468.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CAVA.
Daily Out/Under-Performance
Portfolio return minus CAVA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CAVA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CAVA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling